Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan/Cisplatin Induction Followed by Surgery in Stage IIIA NSCLC
NCT00003111Phase 2Completed
- Sponsor
- Yale University
- Start
- Apr 1997
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in non-small cell lung cancer (NSCLC), sponsored by Yale University. Started Apr 1997; status: completed.
02
Drugs
irinotecan
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00003111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003111.